Serum Sialic Acid Concentration and Coronary Heart Disease in NIDDM

Pickup, John C.; Mattock, M. B.; Crook, Martin; Chusney, Gary; Burt, Davina Judith; Fitzgerald, Anthony P.

doi:10.2337/diacare.18.8.1100

Cited by 51 publications

(36 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, there was no association between plasma sialic acid concentration and CHD, as has been found previously in the general population (2,15,16) and in men with type 2 diabetes (17). But this finding may be related to the young age of the patients (mean 32.5 years in the men, 33.3 years in the women) and the low prevalence of CHD (9% in men, 12% in women) in the present study.…”

Section: Conclusion -supporting

confidence: 51%

Relationship Between Plasma Sialic Acid Concentration and Microvascular and Macrovascular Complications in Type 1 Diabetes

Pj³

et al. 2001

Diabetes Care

View full text Add to dashboard Cite

The APPENDIX section contains a complete list of centers that participated in the EURODIAB IDDM Complications Study.Abbreviations: AER, albumin excretion rate; CHD, coronary heart disease; CV, coefficient of variation. A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. Relationship Between Plasma Sialic Acid Concentration and Microvascular and Macrovascular Complications in Type 1 DiabetesThe EURODIAB Complications StudyOBJECTIVE -To test the hypothesis that an increased plasma concentration of sialic acid, a marker of the acute-phase response, is related to the presence of diabetic micro-and macrovascular complications in type 1 diabetes. RESEARCH DESIGN AND METHODS -We investigated the relationship betweenplasma sialic acid concentration and nephropathy, retinopathy, neuropathy, and coronary heart disease (CHD) in a cross-sectional survey of 1,369 people with type 1 diabetes. Subjects were participants in the EURODIAB IDDM Complications Study, which involved 31 centers in 16 European countries.RESULTS -There was a significantly increasing trend of plasma sialic acid with severity of retinopathy (P Ͻ 0.001 in men) and with degree of urinary albumin excretion (P Ͻ 0.001 men, P Ͻ 0.01 women). Plasma sialic acid correlated with increasing plasma creatinine concentration (P Ͻ 0.009 men, P Ͻ 0.0002 women), and men with neuropathy had a higher plasma sialic acid concentration than those without (P Ͻ 0.006). There was no significant correlation between plasma sialic acid and CHD in either sex. Elevated plasma sialic acid concentrations were also associated with several risk factors for diabetic vascular disease: diabetes duration, HbA 1c , plasma triglyceride and cholesterol concentrations, waist-to-hip ratio, hypertension and smoking (in men), and low physical exercise (in women). In multiple logistic regression analysis, plasma sialic acid was independently related to proliferative retinopathy and urinary albumin excretion rate in men.CONCLUSIONS -We conclude that an elevated plasma sialic concentration is strongly related to the presence of microvascular complications in type 1 diabetes, especially retinopathy and nephropathy. Further study of acute-phase response markers and mediators as indicators or predictors of diabetic microvascular complications is therefore justified.

show abstract

Section: Conclusion -supporting

confidence: 51%

Relationship Between Plasma Sialic Acid Concentration and Microvascular and Macrovascular Complications in Type 1 Diabetes

Pj³

et al. 2001

Diabetes Care

View full text Add to dashboard Cite

show abstract

“…Firstly, it may be caused by the NIDDM state, though apparently not by hyperglycaemia, since there is no correlation between serum sialic acid concentrations and either glycated haemoglobin or plasma glucose levels [12]. Recently, we showed in animal models of diabetes that insulin deficiency is significantly related to elevated serum sialic acid concentrations [45]; moreover, insulin is an inhibitor of acute-phase protein synthesis in vitro [46,47].…”

Section: Discussionmentioning

confidence: 99%

“…In previous studies [8,9], we found that serum sialic acid concentrations are elevated in NIDDM but not in subjects with uncomplicated insulin-dependent diabetes mellitus of comparable age, sex, diabetes duration and glycaemic control (serum sialic acid is essentially protein-bound and has been proposed as a marker of the overall acute-phase response [10] since many acute-phase proteins such as ct-1 acid glycoprotein and fibrinogen are sialylated at the terminus of the oligosaccharide chain of the glycoprotein [11]). The serum sialic acid concentration was also a highly significant univariate correlate of coronary heart disease (CHD) in a cross-sectional study of male NIDDM patients [12]. Others have reported that experimental induction of an acute-phase response in animals [13] and illnesses in humans likely to be associated with an acute-phase response, such as malignancy [14,15] and infection [16], are characterised by serum lipid and lipoprotein changes identical to those of NIDDM and syndrome X (high serum VLDL triglyceride, low HDL ~holesterol, unchanged LDL cholesterol).…”

mentioning

confidence: 99%

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

et al. 1997

View full text Add to dashboard Cite

“…There is also evidence that Lp(a) lipoprotein, which is associated with coronary heart disease in Type II diabetes [26,27], is an acutephase protein [9,28]. 2 A model for the role of cytokines and the innate immune system in the aetiology of Type II diabetes.…”

Section: Evidence For An Acute-phase Response In Type II Diabetesmentioning

confidence: 99%

Is Type II diabetes mellitus a disease of the innate immune system?

1998

View full text Add to dashboard Cite

The cause of the common type of Type II (non-insulin-dependent) diabetes mellitus, which affects at least 100 million people throughout the world, is not known. One of the foremost challenges we face is to account mechanistically for not only the defining hyperglycaemia but also for the myriad of other biochemical and physiological abnormalities which are characteristic of this disease. For example, it is now clear that Type II diabetes and lesser degrees of glucose intolerance commonly occur together with a collection of clinical and biochemical features which have been called metabolic syndrome X [1, 2].These features include central obesity, hypertension, accelerated atherosclerosis, hypertriglyceridaemia and low serum concentrations of high-density lipoprotein (HDL) cholesterol. Though insulin resistance seems to be a central abnormality, the origin of the impaired insulin action and how it explains the many other abnormalities of Type II diabetes is not known.In recent years, we have been gathering evidence that in Type II diabetes there is a cytokine-associated acute-phase reaction, part of the innate immune response. As an alternative direction for research into the aetiology of Type II diabetes, we propose that it may be helpful to consider whether the mechanisms involved in the acute-phase response can be major contributors to the pathophysiology of many of the features of Type II diabetes and syndrome X, including glucose intolerance, insulin resistance, impair- Diabetologia (1998) Summary Type II (non-insulin-dependent) diabetes mellitus is associated with increased blood concentrations of markers of the acute-phase response, including sialic acid, a-1 acid glycoprotein, serum amyloid A, C-reactive protein and cortisol, and the main cytokine mediator of the response, interleukin-6. The dyslipidaemia common in Type II diabetes (hypertriglyceridaemia and low serum levels of HDL cholesterol) is also a feature of natural and experimental acutephase reactions. We review evidence that a long-term cytokine-mediated acute-phase reaction occurs in Type II diabetes and is part of a wide-ranging innate immune response. Through the action of cytokines on the brain, liver, endothelium, adipose tissue and elsewhere, this process could be a major contributor to the biochemical and clinical features of metabolic syndrome X (glucose intolerance, dyslipidaemia, insulin resistance, hypertension, central obesity, accelerated atherosclerosis) but also provides a mechanism for many other abnormalities seen in Type II diabetes, including those in blood clotting, the reproductive system, metal ion metabolism, psychological behaviour and capillary permeability. In the short-term, the innate immune system restores homeostasis after environmental threats; we suggest that in Type II diabetes and impaired glucose tolerance long-term lifestyle and environmental stimulants, probably in those with an innately hypersensitive acute-phase response, produce disease instead of repair. [Diabetologia (1998

show abstract

Serum Sialic Acid Concentration and Coronary Heart Disease in NIDDM

Cited by 51 publications

References 25 publications

Relationship Between Plasma Sialic Acid Concentration and Microvascular and Macrovascular Complications in Type 1 Diabetes

Relationship Between Plasma Sialic Acid Concentration and Microvascular and Macrovascular Complications in Type 1 Diabetes

NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

Is Type II diabetes mellitus a disease of the innate immune system?

Contact Info

Product

Resources

About